NasdaqGS - Delayed Quote USD

Materialise NV (MTLS)

Compare
5.14 -0.18 (-3.38%)
At close: October 2 at 4:00 PM EDT
Loading Chart for MTLS
DELL
  • Previous Close 5.32
  • Open 5.27
  • Bid 5.11 x 100
  • Ask 5.15 x 200
  • Day's Range 5.13 - 5.31
  • 52 Week Range 4.70 - 6.93
  • Volume 58,653
  • Avg. Volume 131,511
  • Market Cap (intraday) 303.605M
  • Beta (5Y Monthly) 1.13
  • PE Ratio (TTM) 24.48
  • EPS (TTM) 0.21
  • Earnings Date Jul 31, 2024
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est 10.19

Materialise NV provides additive manufacturing and medical software, and 3D printing services in the Americas, Europe and Africa, and the Asia-Pacific. The company operates through three segments: Materialise Software, Materialise Medical, and Materialise Manufacturing. The Materialise Software segment offers software through programs and platforms that enable and enhance the functionality of 3D printers and of 3D printing operations. Its software interfaces between various types of 3D printers; and various software applications and capturing technologies, including computer-aided design/computer-aided manufacturing packages and 3D scanners. This segment serves 3D printing machine manufacturers; production companies and contract manufacturers in automotive, aerospace, consumer goods, and hearing aid industries; and 3D printing service bureaus through its sales force, Website, and third party distributors. The Materialise Medical segment provides medical software that allows medical-image based analysis, planning, and engineering, as well as patient-specific design and printing of surgical devices and implants. It serves medical device companies, hospitals, universities, research institutes, and industrial companies through its direct sales force, Website, and picture archiving and communication system. The Materialise Manufacturing segment provides 3D printing services, design and engineering services, and rapid prototyping and additive manufacturing of production parts to industrial and commercial customers. The company has collaboration agreements with Zimmer Biomet Holdings, Inc.; Encore Medical, L.P.; DePuy Synthes Companies of Johnson & Johnson; Limacorporate Spa; Mathys AG; Corin Ltd; Smith & Nephew Inc.; Corin Ltd; Medtronic Inc.; and Abbott Laboratories Inc. Materialise NV was incorporated in 1990 and is headquartered in Leuven, Belgium.

www.materialise.com

2,437

Full Time Employees

December 31

Fiscal Year Ends

Recent News: MTLS

View More

Performance Overview: MTLS

Trailing total returns as of 10/3/2024, which may include dividends or other distributions. Benchmark is

.

YTD Return

MTLS
21.77%
MSCI WORLD
16.22%

1-Year Return

MTLS
5.51%
MSCI WORLD
29.74%

3-Year Return

MTLS
73.87%
MSCI WORLD
21.84%

5-Year Return

MTLS
71.79%
MSCI WORLD
73.61%

Compare To: MTLS

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: MTLS

View More

Valuation Measures

Annual
As of 10/2/2024
  • Market Cap

    303.61M

  • Enterprise Value

    228.18M

  • Trailing P/E

    24.22

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    1.05

  • Price/Book (mrq)

    1.12

  • Enterprise Value/Revenue

    0.79

  • Enterprise Value/EBITDA

    5.87

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    4.25%

  • Return on Assets (ttm)

    2.67%

  • Return on Equity (ttm)

    4.59%

  • Revenue (ttm)

    257.86M

  • Net Income Avi to Common (ttm)

    10.96M

  • Diluted EPS (ttm)

    0.21

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    125.49M

  • Total Debt/Equity (mrq)

    23.84%

  • Levered Free Cash Flow (ttm)

    12.32M

Research Analysis: MTLS

View More

Earnings Per Share

Consensus EPS
 

Revenue vs. Earnings

Revenue 68.8M
Earnings 3.88M
 

Analyst Recommendations

  • Strong Buy
  • Buy
  • Hold
  • Underperform
  • Sell
 

Analyst Price Targets

9.44
10.19 Average
5.14 Current
11.93 High
 

Company Insights: MTLS

People Also Watch